Cargando…

An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer

The American Joint Committee on Cancer (AJCC) staging system is insufficiently prognostic for gastric cancer (GC) patients and complementary factors are in urgent need. Here we aimed to develop a comprehensive model, consisting of both immune signatures and cancer signaling molecules, which was expe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Xiaofang, Jia, Shuqin, Leng, Yuxin, Wang, Qian, Li, Zhongwu, Dong, Bin, Guo, Ting, Cheng, Xiaojing, Du, Hong, Hu, Ying, Feng, Qin, Lian, Shenyi, Luan, Fengming, Ma, Xiaoxiao, Li, Zhe, Ni, Ming, Li, Ziyu, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470183/ https://www.ncbi.nlm.nih.gov/pubmed/32939321 http://dx.doi.org/10.1080/2162402X.2020.1792038

Ejemplares similares

Clinicopathological and Immunomicroenvironment Characteristics of Epstein–Barr Virus-Associated Gastric Cancer in a Chinese Population
por: Jia, Xiaoxia, et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)

Correction: Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2014)

MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling
por: Huangfu, Longtao, et al.
Publicado: (2021)

Characterization of glycometabolism and tumor immune microenvironment for predicting clinical outcomes in gastric cancer
por: Shi, Jinyao, et al.
Publicado: (2023)

TNFRSF11B activates Wnt/β-catenin signaling and promotes gastric cancer progression
por: Luan, Fengming, et al.
Publicado: (2020)

TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
por: Ma, Xiaoxiao, et al.
Publicado: (2023)

Molecular characteristics of synchronous multiple gastric cancer
por: Wang, Anqiang, et al.
Publicado: (2020)

PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
por: Xing, Xiaofang, et al.
Publicado: (2014)

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients
por: Li, Ziyu, et al.
Publicado: (2016)

WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways
por: Ji, Jiafu, et al.
Publicado: (2015)

Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer
por: Yang, Yang, et al.
Publicado: (2021)

Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
por: Sun, Shuning, et al.
Publicado: (2023)

Accurate and Rapid Detection of Peritoneal Metastasis from Gastric Cancer by AI‐Assisted Stimulated Raman Molecular Cytology
por: Chen, Xun, et al.
Publicado: (2023)

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer
por: Zhang, Meng, et al.
Publicado: (2023)

Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer
por: Hao, Chengcheng, et al.
Publicado: (2021)

Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer
por: Cui, Yuxin, et al.
Publicado: (2021)

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection
por: Wang, Xiaohong, et al.
Publicado: (2017)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction
por: Deng, Ziqian, et al.
Publicado: (2023)

SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis
por: Han, Jing, et al.
Publicado: (2022)

EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway
por: Wang, Lin, et al.
Publicado: (2019)

TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2020)

Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2022)

CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways
por: Han, Jing, et al.
Publicado: (2021)

CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways: Erratum
por: Han, Jing, et al.
Publicado: (2023)

Establishment of a SVM classifier to predict recurrence of ovarian cancer
por: Zhou, Jinting, et al.
Publicado: (2018)

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
por: Zhang, Lianhai, et al.
Publicado: (2013)

PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma
por: Song, Qian, et al.
Publicado: (2021)

Reporting accuracy of rare event classifiers
por: Pinker, Edieal
Publicado: (2018)

A Chinese family affected by lynch syndrome caused by MLH1 mutation
por: Jia, Shuqin, et al.
Publicado: (2018)

PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer
por: Lian, Shenyi, et al.
Publicado: (2016)

A random forest classifier predicts recurrence risk in patients with ovarian cancer
por: Cheng, Li, et al.
Publicado: (2018)

Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model
por: Cao, Maomao, et al.
Publicado: (2020)

Identification of “regulation of RhoA activity panel” as a prognostic and predictive biomarker for gastric cancer
por: Huang, Wenwen, et al.
Publicado: (2020)

Case report: anaesthetic management of radical gastrectomy for gastric cancer associated with anti-N-methyl-D-aspartate receptor encephalitis
por: Ding, Lei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5latus2oqqvco2j58r2d9bmuq1